Merck & Co to buy Afferent for neurology drugs

Deal worth up to $1.25bn includes drug candidate for chronic coughs

Source: Chemistry World | Latest News - June 13, 2016 Category: Chemistry Authors: Phillip Broadwith Source Type: research